Dr. Jessica Walter recently published an article in the Journal of the American Academy of Dermatology to assess gender-specific fertility risk for Food and Drug Administration (FDA)-approved melanoma therapies with a new risk category system. The article “Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies” appears in the September issue. To read the article in its entirety, click here.